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The central role of RNA in the regulation of many vital processes,
occurring under both physiological and pathological conditions, has
emerged clearly over the past 10 years (for a very recent review see
[1]. As a consequence, most ribonucleases have received a consid-
erable interest for their association with health and diseases,
including human cancer development [2], and are consideredpotential targets for drug design [3] because of their strong cytotoxic
activity toward malignant tumor cells. One of the enzymes of this
class, the amphibian Onconase, reached also clinical trials [4]. Dif-
ferent RNAs are degraded by these proteins, whose antitumor activ-
ity is critically dependent on a complex series of biochemical events,
involving interactions with different cellular compartments. The
crucial steps of this process include binding to negatively charged
cell membrane, translocation into the cytosol via endocytosis [5]
and RNA degradation. Furthermore, to fully exploit their antitumor
potential, ribonucleases have to resist to protease attack and to evade
Ribonuclease Inhibitor [6], a 50 kDa horse-shoe shaped protein that
binds with very high afﬁnity most monomeric ribonucleases and
hampers their activity [7]. Previous structure-activity relationship
studies allowed the identiﬁcation of the crucial features that these
enzymes have to fulﬁll to exhibit antitumor activity: i) a strong
positive surface potential to allow membrane interaction; ii) a
functional catalytic site and iii) a 3D structure able to evade Ribo-
nuclease Inhibitor.
In principle, it is possible to increase the antitumor potentiality
of ribonucleases by chemical modiﬁcations or protein engineering but
until now this target remained essentially elusive. Enforcing the
cytotoxicity by inﬂuencing the enzymatic activity is not straightforward;
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is no direct correlation between catalytic efﬁciency and antitumor
potentiality [8]. On the other hand, the enhancement of RI resistance is
more feasible, since RNase A and human pancreatic ribonuclease
variants designed to avoid binding were found to be cytotoxic [9,10].
Strategies to enhance ribonucleases ability to evade RI have been
inspired by naturally occurring antitumor ribonucleases, which avoid
binding because either they lack residues directly involved in the
complex with RI, like in the case of Onconase, or their 3D structure
does not allow the formation of a stable complex with RI. This has a
paradigmatic example in bovine seminal ribonuclease (BS-RNase) [11],
which shows antitumor activity in vitro and on model animals [12]. BS-
RNase is a dimeric protein constituted by two identical subunits
covalently linked through two disulﬁde bridges (for a review, see [7]);
it is isolated as an equilibrium mixture of two isoforms, with or
without exchange (swapping) of the N-termini, indicated as MxM and
M=M respectively [13]. X-ray structures [14,15] revealed that the two
isoforms present only minor differences in their tertiary structure,
located essentially at level of 16–22 hinge region, i.e. the loop
connecting the dislocating extremity to the protein body. However,
under reducing conditions, the two isoforms behave differently: the
swapped form, being converted into a so-called non-covalent dimer
(NCD), still evades RI binding [16], whilst the unswapped one
dissociates into two monomers, which are inactivated by RI. Thus, it
could be hypothesized that an increasing of the MxM fraction with
respect to M=M should result in an increased ability to evade RI and,
consequently, in a higher antitumor activity. However, we have
obtained enzymatically active BS-RNase variants with the same
swapping amount of the native protein but a very low antitumor
activity [17], suggesting that the swapping per se is not sufﬁcient to
elicit the antitumor activity, and making the relationships between
swapping and cytotoxicity still complicated.
As last strategy to enhance ribonucleases antitumor activity one
could act on their internalization efﬁciency, relying on the pieces of
evidence that ribonucleases directly injected into the cytosol are
more toxic than those added to cells externally [18]. Also in this
case, natural ribonucleases are useful templates for protein engi-
neering. A correlation with the number of positive charges on the
protein surface and the cytotoxic activity has been already reported
for several vertebrate ribonucleases, including Onconase [19], RNase
A oligomers [20] and BS-RNase [21]. Particularly, in comparison with
RNase A, the higher pI of BS-RNase enhances the interaction with
phospholipid membranes and allows a better internalization [22]. In
addition, based on in silico studies, it has been proposed that the
BS-RNase face interacting with membrane is the one hosting the
N-termini (henceforth designed N-face) which, in the native protein,
is characterized by a large positive potential that promotes a strong
interaction with the negatively charged phospholipids of the cellular
membrane [21]. However, this hypothesis has not been experimen-
tally proved so far.
Based on these premises, in this paper we have explored the
possibility to strengthen the antitumor activity of BS-RNase by
improving the protein/membrane through the enhancement of the
positive potential of this same surface, i.e. we have produced
the G38K-BS-RNase variant (henceforth called G38K), and found
that it shows a higher cytotoxicity toward tumor cells. Since this
variant does not present any change both in the catalytic activity
and in the ability to evade RI, we hypothesized the higher cyto-
toxicity to be connected to its enhanced interaction with mem-
branes. To support this idea, we performed a detailed investigation
of the membrane interaction process of BS-RNase and G38K with
synthetic liposomes by using a combination of biophysical techniques.
These studies shed light on the mechanism of membrane interaction,
proving deﬁnitely the importance of electrostatic interactions in the
cytotoxic activity toward tumor cells, and can be helpful to design
proteins with even improved antitumor potentiality.2. Materials and methods
2.1. Homology modeling and electrostatic potential calculation
The homology model of the G38K variant was calculated upon the
crystal structure of the swapped BS-RNase (pdb code 1BSR) using
Modeller 8v5 program [23]. The quality of the structural models was
evaluated with the same program using the score of variable target
function method [24]. Model analyses were performed using MOLMOL
[25] and PyMOL [26]. The electrostatic potential was calculated using
the program MGLTools-PMV.
2.2. Determination of electrostatic energy of interaction with
charged membranes
The orientation-dependent electrostatic free energy due to the
presence of a uniform electrostatic ﬁeld generated by a charged
membrane was computed by solving the Poisson-Boltzmann equation
using the program DELPHI4 [27]. Similar to the modeling study of
Notomista et al. [21] we assumed a surface charge density of 192
negative charges distributed over an area of 117×108 Å2, which
results in a strong uniform electrostatic ﬁeld of 0.352×109 V/m in the
direction of the z-axis. The dimerwas placed at a distance of 55 Å from
the membrane, in order to avoid close contacts which are difﬁcult to
describe with a continuum model. The molecule was then rotated in
steps of 30° around the z-axis. For each rotation a second rotation
around the x-axis in steps of 30° was applied. A third rotation around
the z-axis should be applied to complete the rotational space
sampling. This was not done because of the symmetry of the applied
electric ﬁeld.
2.3. Protein samples
The QuikChange Site-Directed Mutagenesis Kit protocol (Strata-
gene, La Jolla, CA) was used to substitute glycine 38 with lysine
(G38K) in pET-22b(+) plasmid cDNA coding for BS-RNase, already
available in our laboratory, which contained the N67D substitution to
avoid local heterogeneity arising from the spontaneous deamidation
occurring at position 67 [28,29].
The monomeric derivatives of BS-RNase and its G38K variant were
expressed in E. coli cells and puriﬁed as previously described [30,31],
with cysteines 31 and 32 linked to two glutathione molecules. Once
assessed the purity of the protein samples and the correctness of
their fold by gel-electrophoresis, CD and 2D NMR analysis, the enzy-
matic activity on yeast RNA was evaluated as usual [32] and found
very close to each other for the two proteins, and also close to the
literature data. The monomers were converted in the corresponding
dimers following the procedure already reported [33]; as usual, the
main product at the ﬁrst puriﬁcation step was the unswapped dimer.
The protein solutions were then incubated at 37 °C to allow the
conformational equilibrium between swapped and unswapped iso-
forms; the swapping extent was then assessed by two independent
methods, as reported before [34], and found about 70% for both the
recombinant proteins, as in native BS-RNase. Also for the dimeric
form of G38K the enzymatic activity on yeast RNA was found very
close to that of the parent BS-RNase.
2.4. Cytotoxicity studies
Before the cytotoxicity assays, the N-terminal methionine was
removed with Aeromonas proteolytica aminopeptidase (Sigma) [35].
Cytotoxicity of BS-RNase andG38Kwas evaluated byperforming the
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
reduction inhibition assay [36]. Simian-virus-40-transformed mouse
ﬁbroblasts (SVT2 cells) and the parental non transformed Balb/C 3T3-
line (3T3 cells) were obtained from the A.T.C.C. (American Type Culture
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Eagle's medium (DMEM) supplemented with 10% fetal bovine serum,
4 mM glutamine, 400 units/ml penicillin and 0.1 mg/ml streptomycin.
Cell lines were maintained at 37 °C in a humidiﬁed incubator contain-
ing 5% CO2. The cells were plated on 96-well plates at a density of
2.5×103 cells/well in 100 μl of medium containing either BS-RNase
or the G38K variant up to a ﬁnal protein concentration of 25, 50 and
100 μg/ml, corresponding to 0.9, 1.8 and 3.6 μM respectively. After 24,
48 and 72 h of incubation, 10 μl of a 5 mg/ml stockMTT solution in PBS,
corresponding to a ﬁnal concentration of 0.5 mg/ml in DMEM (ﬁnal
volume 100 μl), were added to the cells. After incubation of 4 h theMTT
solution was removed and the MTT formazan salts were dissolved in
100 μl of 0.1 N HCl in anhydrous isopropanol. Cell survival is expressed
as the absorbance of blue formazan measured at 570 nm with an
automatic plate reader (Victor3 Multilabel Counter, Perkin Elmer,
Shelton, CT).
2.5. CD spectra measurements and check of the protein stability vs. T
The CD spectra were recorded with a Jasco J-715 spectropolari-
meter equipped with a Peltier type temperature control system
(Model PTC-348WI). A protein concentration of about 0.3 mg ml−1
(about 10.8 μM) in 10 mM sodium acetate buffer, pH 5.0, was used.
Thermal unfolding curves were recorded in the temperature scan
mode at 222 nm from 25 up to 85 °C with a scan rate of 1.0 °C min−1.
For each protein sample, Tm vas calculated by nonlinear regression
analysis of the experimental data, as the value corresponding to the
midpoint of the denaturation curve. The full reversibility of thermal
transition was assessed by CD for all proteins, since the CD curves
were completely recovered upon cooling the protein solutions at
room temperature. CD spectra and thermal denaturation measure-
ments were acquired also in the presence of dimyristoyl phosphati-
dylglycerol (DMPG) large unilamellar vesicles (LUVs, see Section 2.6)
using a protein/phospholipid ratio 1:100 w/w.
2.6. Phospholipid bilayer preparation
To experimentally study the interaction between proteins and
lipid membranes, SPR, ESR and CD experiments were performed on
BS-RNase or G38K in the presence of bilayers formed by dilauroyl
phosphatidylglycerol (DLPG), in the form of supported bilayers (for
SPR measurements) or liposomes (for ESR and CD measurements).
Bilayers to be used for ESR measurements also included 1% w/w of
spin-labeled phosphatidylcholines (n-PCSL) with the nitroxide group
at different positions, n, in the sn-2 acyl chain. DLPG and spin-labels
were obtained from Avanti Polar Lipids (Birmingham, AL, USA) and
used without further puriﬁcation.
Phospholipid liposomes were prepared by dissolving the lipids in a
CHCl3/MeOH mixture (2/1 v/v). The solvents were then evaporated
under a stream of nitrogen, and the lipids were subjected to a vacuum
for at least 3 h and then resuspended in sodium acetate buffer 10 mM
pH 5.0 by vortexing. The resulting dispersions contained multi-
lamellar vesicles (MLVs) that were used as such for ESR experi-
ments. To perform CD measurements, large unilamellar vesicles
(LUVs), preferred for their lower scattering, were obtained fromMLVs
by extrusion 11 times through polycarbonatemembranes with 0.1 μm
diameter pores. In the case of SPR experiments, supported lipid
bilayer were prepared starting from small unilamellar vesicles (SUVs)
prepared by sonication of MLVs, following the protocol previously
described [37].
2.7. Binding analysis to liposomes by surface plasmon resonance (SPR).
SPR experiments were carried out with a BIAcore 3000 analytical
system (Biacore, Uppsala, Sweden) using the L1 sensor chip and an
experimental protocol previously described by Mozsolits et al. [38].The running buffer used for all experiments was sodium acetate
10 mM pH 5.0; the washing solution was 40 mM N-octyl β-D-
glucopyranoside (25 μl, 5 μl/min). All solutions were freshly prepared,
degassed, and ﬁltered through 0.22 μm pores. DLPG SUVs (80 μl,
0.5 mM) were then applied to the chip surface at a ﬂow rate of
2 μl/min at a temperature of 25 °C. To remove any multilamellar
structures from the lipid surface, we used NaOH 10 mM and increased
the ﬂow rate to 50 μl/min, which resulted in a stable baseline
corresponding to the lipid bilayer linked to the chip surface. The
negative control BSA was injected (25 μl, 0.1 mg/μl in sodium acetate
buffer) to conﬁrm complete coverage of the nonspeciﬁc binding sites.
A range of contact times and ﬂow rates have been examined. BS-
RNase and G38K solutions (200 μl, 600 s) were injected onto the lipid
surface at a ﬂow rate of 20 μl/min to avoid limitation by mass transfer.
On completion of injection, buffer ﬂow continued for 15 min to allow
protein dissociation. A sensorgram was obtained by plotting the SPR
angle against time. This change in the angle is then translated to
response units and the protein-lipid binding event was characterized
from a series of sensorgrams collected at different protein concen-
trations (5 nM–50 nM).
The sensorgrams were analyzed by curve ﬁtting using numerical
integration analysis [39]. The BIAevaluation routine was used to per-
form complete kinetic analyses of the peptide sensorgrams. Several
curve ﬁtting algorithms were used but good ﬁt was obtained only
with the two-state reaction model, which was previously used for
describing the possible binding mechanisms of antimicrobial pep-
tides. The data were ﬁtted globally by simultaneously ﬁtting the
sensorgrams obtained at different protein concentrations and the
two-state reactionmodel was applied to each dataset. This model [38]
describes two reaction steps:
P + L⇌
Ka1
kd1
PL⇌
ka2
kd2
PL
The two steps may correspond to the protein (P) binding to lipids
(L) to give PL and to the complex PL changing to PL*, which cannot
dissociate directly to P+L and which may correspond to partial
insertion of the protein into the lipid bilayer. The corresponding
differential rate equations for this reaction model are:
dRU1 = dt = ka1 × CA × RU max−RU1−RU2ð Þ−kd1 × RU1−ka2 × RU1
+ kd2 × RU2dRU2 =
dt = ka2 × RU1−kd2RU2
where RU1 and RU2 are the response units for the ﬁrst and second
steps, respectively, CA is the protein concentration, RUmax is the
maximum protein binding capacity (or equilibrium binding re-
sponse), and ka1, kd1, ka2, and kd2 are the association and dissociation
rate constants for the ﬁrst and second steps, respectively.
While ka1 has M−1 s−1 units, kd1, ka2, and kd2 have s−1 units; thus
the total afﬁnity constant for the all process, KA, hasM−1 units. Kinetic
data were assessed by using χ2 values, plots of the residuals from the
model ﬁtting and the signiﬁcance of a parameter assessed by standard
deviations. The quality of the ﬁt to a speciﬁc parameter was deemed
signiﬁcant if the standard deviation was less than 10%.
2.8. Electron spin resonance spectroscopy
Samples for ESR spectroscopy were prepared by mixing in small
test tubes appropriate amounts of lipid in dichloromethane/methanol
(2/1 v/v) and spin-labeled phosphatidylcholines in ethanol, following
the procedure described above. The proteins were dissolved in the
sodium acetate buffer 10 mM, pH 5.0, used to re-hydrate the lipid
sample, mixed with the lipid solutions (typical volume 30–50 μl),
heated above the lipid phase transition temperature with intermittent
vortexing, and ﬁnally transferred to a 25 μL glass capillary.
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spectrometer, at 25 °C, using procedures and instrument setting
reported in literature [40].
In order to quantitatively analyze the spectra, the order param-
eter, S, and the isotropic nitrogen hyperﬁne coupling constant, a′N,
were calculated according to a well-established model reported in
the literature [41]. Values of the phenomenological hyperﬁne
splitting parameters necessary to apply the model were determined
by a home-made MATLAB-based routine, that ﬁts the maxima and
minima in the outer wings of a spectrum empirically to a Gaussian
curve and calculates the ﬁeld difference between the extrema [42].
Uncertainty on ESR parameters was estimated by evaluating their
values for independently prepared samples with the same nominal
composition.
3. Results and discussion
3.1. Rational protein design
In order to produce a variant with an increased positive potential
at the N terminus region, without altering the fold and the activity
of the BS-RNase, we have inspected the N-face of the protein, whichFig. 1. (A) Electrostatic surface of the G38K. (B) Structure of the BS-RNase model membrane
and colored according to the atom type. (C) Structure of the G38K model membrane compl
colored according to the atom type.has already a strong positive potential and, for this reason, has been
supposed to represent the membrane-interacting face of the protein
[21]. To enhance this positive potential, we decided to mutate a well
exposed surface residue, glycine 38, to a lysine. The homology model
of the G38K variant based on the crystal structure of the swapped
dimer of BS-RNase (1BSR) conﬁrmed a very close similarity among
the two proteins. We compared also the electrostatic potential at the
solvent accessible surfaces of G38K and BS-RNase and found, as
expected, a strong polarity with a positive potential located at the
N-terminus side in both cases but, as illustrated in Fig. 1A, the
introduction of a basic residue at position 38 in the G38K variant
creates an almost continuous patch of positive charges spanning
from K39 of one subunit to K39 of other one, which includes also the
two K1 residues. This feature is expected to increase the membrane
binding capability.
We have then calculated the electrostatic interaction energy (EIE)
between wild type BS-RNase and its G38K variant and negatively
charged model membrane made of DMPG lipids assembled as
previously reported in Notomista et al. [21]. A series of EIE values
were calculated by varying the orientation of each RNase toward the
membrane. The results of these calculations revealed that, for both
BS-RNase and G38K, a single highest negative value of EIE could becomplex with the highest negative EIE value. Lipids are shown as van derWaals spheres
ex with the highest negative EIE value. Lipids are shown as van der Waals spheres and
Fig. 2. Effects of RNase on the proliferation of murine malignant SVT2 ﬁbroblasts. Cells,
after a preliminary incubation for 24 h at 37 °C, were subjected to the presence of
different amounts (25, 50 and 100 μg/L, corresponding to 0.9, 1.8 and 3.6 μM respec-
tively) of BS-RNase and G38K for 24 h, 48 h and 72 h. Each value is the mean of at least
three determinations and is expressed as percentage of the control, in which cells were
grown in the absence of RNases.
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when the N-terminus region of the proteins is oriented toward the
membrane (Fig. 1B and C). G38K has a better interaction with the
membrane compared to BS-RNase, indeed the lowest value of inter-
action energy for G38K is about 20 kcal/mol below the corresponding
one of BS-RNase. This difference suggests that electrostatics is
important for the interaction with the membrane and that the G38K
substitution may improve this interaction. On the basis of these
data we decided to insert this mutation in the construct coding for
BS-RNase.
3.2. Biochemical properties
The cytotoxic activity of BS-RNase and G38K was evaluated by
measuring the proliferation of malignant SVT2 ﬁbroblasts, both in
dose-dependent and time-dependent assays. The results are illustrated
in Fig. 2, reporting the cell survival after 24, 48 and 72 h of incu-
bation following the protein addition. The curves indicate that in all
the experimental conditions examined G38K displays a stronger
cytotoxic activity, the percentage of cell survival being always lower
than in the presence of the same amount of the parent BS-RNase.
The cytotoxic activity is quite small after 24 h of incubation, the cell
survival remaining in all conditions above 50%, and even the dif-
ference between the two proteins is not very evident: as an exam-
ple, upon addition of 50 μg/ml of protein, the cell survival in the
presence of G38K is only 15% lower than that observed with the
parent BS-RNase. The different effect of the two proteins is more
evident after 48 and 72 h when cell survival in presence of G38K is
65 and 70% lower than with BS-RNase. Furthermore, after 48 h there
is a more clear dose dependent effect for both proteins, the per-
centage of alive cells being below 20% in the presence of 50 μg/mL of
G38K and about 40% in the presence of the same amount of
BS-RNase. Finally, after 72 h, a maximum of 15% of cell survival with
respect to the untreated cells is observed with G38K, even in the
presence of the lowest protein concentration utilized in this assay,
i.e. 0.9 μM, while BS-RNase shows still a dose dependent activity. As
expected, when assayed in the same experimental conditions, both
proteins have no effects on the normal 3T3 cells (data not shown).
It is worth to recall here that an increased cytotoxic activity with
respect to BS-RNase was obtained by Raines and coworkers [43] with
the G38K/K39G/G88R-BS-RNase variant, which displayed antitumor
activity even at monomeric state, due to a better resistance of the
monomeric derivative to inhibition by RI [43]. However the authors
attributed this property to the steric encumbrance of R88, which
hinders the contact with W259 of RI, and to the abolition of the
electrostatic interaction between K39 and E297 observed in the RNase
A/RI complex [44], therefore the speciﬁc inﬂuence of the G38K substi-
tution could not be isolated. Therefore, we decided to investigate the
molecular basis of the cytotoxic activity of BS-RNase and its G38K
variant, focusing on the mechanism of interaction with models of
phospholipid membranes.
3.3. Circular dichroism spectra
It is well known from literature data that pancreatic-like ribo-
nucleases are very stable proteins, with melting temperatures above
50 °C. Anyhow, to rule-out side-effects on the protein conformation
and stability following liposome interaction, we have checked the
BS-RNase and G38K conformation by Circular Dichroism studies in a
wide temperature range (25–85 °C). CD thermal denaturation curves,
acquired as described in detail in the experimental section, proved
that both the proteins were completely stable around physiological
temperatures, with Tm of 62 °C for BS-RNase and 60 °C for G38K.
Furthermore, their conformation is not affected by liposomes, as no
substantial differences in CD spectra or Tm were detected in the
presence of DMPG liposomes. CD spectra at 25 °C of both the proteinswith and without liposomes are reported in the Supporting Material
(Fig. S1).
3.4. Membrane binding
We used the Biacore biosensor method to investigate the inter-
action between BS-RNase or its G38K variant with lipid bilayers. Since
our modeling studies have shown that the driving force of this inter-
action is essentially electrostatic, we decided to use an anionic lipid,
DLPG. Dilauroyl phospholipids, which are in the ﬂuid state at 25 °C,
have shown to be a good option for studies conducted around room
temperature [42]. DLPG bilayers were absorbed onto the L1 chip.
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The sensorgrams reveal that the RU signal intensity increases as a
function of the protein concentration. This indicates that the amount
of protein bound to liposomes is proportional to the protein
concentration. The sensorgrams of the binding of the native protein
compared to the variant show markedly lower response levels, indi-
cating a stronger binding to liposomes of the variant protein (maxi-
mum concentration for G38K is 20 nM, while for BS-RNase is 50 nM).
The inspection of the shape of each sensorgram reveals that the
proteins bind to the lipid surfaces in a biphasic manner, with a more
evident effect for the native protein. The initial association starts as
a fast process and then slows down considerably toward the end of
the injection. Moreover, the sensorgrams do not return to zero, indi-
cating that the proteins remained signiﬁcantly bound to the surface or
inserted into the bilayer membrane.
We employed numerical integration analysis that uses nonlinear
analysis to ﬁt an integrated rate equation directly to the sensor-
grams [45]. When ﬁtting the protein's sensorgrams globally (using
different concentrations of the protein) with the simplest 1:1
Langmuir binding model, a poor ﬁt was obtained (χ2N100), conﬁrm-
ing that this model does not represent the lipid binding mechanism.
However, a signiﬁcantly improved ﬁt was obtained using numerical
integration of the two-state reaction model of the binding sensor-
grams, suggesting that there is likely to be at least two steps involved
in the interaction between the protein and the bilayer. In analogywith
previous studies of peptide-membrane interactions using SPR
[46–48], the ﬁrst step may correspond to the actual binding of the
protein to the surface, and the second step to the insertion of the
protein into the hydrophobic core of the membrane.BS
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Fig. 3. Sensorgrams for the binding of BS-RNase and G38K with DLPG bilayers (L1 chip).A set of protein sensorgrams with different protein concentra-
tions was used to estimate the kinetic parameters. In this model, the
values of ka1/kd1 and ka2/kd2 correspond to the afﬁnity constants for
electrostatic interaction and hydrophobic interaction, respectively.
The average values for the rate constants obtained from the two-
state model analysis are listed in Table 1 along with the afﬁnity
constant values (KA). These data clearly indicate the main inﬂuence
on the overall binding constant of the fast association rate and slow
dissociation rate of the ﬁrst step. If this step corresponds to the
electrostatic interaction, these results clearly conﬁrm that electro-
static forces play an important role in the binding of the protein. The
higher afﬁnity constants obtained for G38K is the result of an
enhancement of the ﬁrst step and not of the second step. This is
because G38K binds approximately 10 fold faster (ka1) to DLPG in
the ﬁrst step, while the binding rate constants are lower in the
second step for both proteins. This indicates that the major differ-
ence between BS-RNase and G38K is in the initial contact with the
bilayer and thus mainly in the electrostatic interaction.
3.5. Membrane interaction
SPR results not only point out the relevance of the initial adsorp-
tion of BS-RNase or G38K on the bilayer surface, essentially driven
by electrostatic interactions, but also indicate that in the following
step both proteins are inserted, at least partially, in the bilayer
hydrophobic core. This point is worth to be investigated in more
detail. Indeed, perturbation of the lipid packing represents the early
stage of protein internalization, regardless of the speciﬁc membrane
translocation mechanism. For this reason, we performed an ESR
investigation on the association of BS-RNase and its variant with
lipid membranes analyzing the perturbation of the chain mobility of
spin-labeled phospholipids [49].
To investigate the depth of penetration of BS-RNase variants into
the anionic phospholipid bilayer, we studied the perturbation that is
induced by binding of BS-RNase or G38K on the ESR spectra of spin
labels at different positions, n, in the sn-2 chain of the lipid. Fig. 4A
gives the ESR spectra of the n-PCSL phosphatidylcholine spin-label
positional isomers incorporated in DLPG bilayer membranes, in the
presence and absence of either BS-RNase or G38K at a protein/lipid
ratio of 1/1 (w/w). In the absence of proteins, the spectrum aniso-
tropy decreases progressively with increasing n, as the spin-label
position is stepped down the chain toward the center of the mem-
brane, a characteristic hallmark of the liquid-crystalline state of ﬂuid
phospholipid bilayers (see, e.g., ref. [40]).
In the presence of BS-RNase, signiﬁcant perturbations of the spec-
tra of spin-labeled phospholipids are observed, due to a protein/
liposome interaction. With respect to the spectra registered in the
absence of the proteins, differences are more evident for G38K than
for BS-RNase, according to an enhanced bilayer perturbation. For
both proteins, differences become less evident with increasing n, i.e.,
for more internal spin-labels.
To quantitatively analyze these results we determined the order
parameter of lipid acyl chains, S, and the nitrogen hyperﬁne coupling
constant, a′N, which is an index of themicropolarity experienced by the
nitroxide label [47]. Both a′N and S decrease progressively withTable 1
Association (ka1, ka2) and dissociation (kd1, kd2) rate constants obtained for the L1 chip
using the two state model.
ka1 (M−1 s−1) kd1 (s−1) ka2(s−1) kd2(s−1) KA(nM−1)
BS-RNase (9.80±0.04)
104
(2.07±0.09)
10-3
(4.90±0.03)
10-2
(2.76±0.01)
10-2
0.131
G38K (6.80±0.09)
105
(1.22±0.03)
10-2
(8.36±0.02)
10-3
(1.55±0.05)
10-3
0.355
The afﬁnity constant (KA) determined as (ka1/kd1)×(ka2/kd2) is for the complete
binding process.
0.66
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affected by the proteins. Perusal of Fig. 4B suggests that G38K and, to a
minor extent, BS-RNase, increase the polarity experienced by the labelFig. 4. (A) ESR spectra of n-PCSL in DLPG bilayer membranes, in the absence
(continuous line) and presence of 1:1 (w/w) BS-RNase (dashed line) and G38K
(dashed-dotted line) at 25 °C. The plot width is 90 G. (B) Dependence on spin-label
position, n, of n-PCSL nitrogen hyperﬁne coupling constant, a′N, in DLPG bilayers, in the
absence (open circles, continuous line) and presence of 1:1 (w/w) BS-RNase (full
squares, dashed line), or G38K (full diamonds, dashed-dotted line). (C) Dependence on
spin-label position, n, of n-PCSL order parameter, S, in DLPG bilayers, in the absence
(open circles, continuous line) and presence of 1:1 (w/w) BS-RNase (full squares,
dashed line), G38K (full diamonds, dashed-dotted line).
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Fig. 5. Dependence of the 5-PCSL order parameter, S, in DLPG bilayers on the
protein/lipid ratio for BS-RNase (full squares, dashed line) and G38K (full diamonds,
dashed-dotted line).in position 5, while at all other label positions a′N variations are within
the experimental uncertainty.
Fig. 4C shows that at each label position, the value of S is increased
by the presence of proteins, i.e. the packing ordering increases and the
rotational dynamics of the spin-labeled chains decreases upon
interaction of both proteins with the membrane, the effect of G38K
being bigger than that of the parent protein. Moreover, the bilayer
surface is more perturbed than its interior. Indeed, in the case of BS-
RNase, the S increase is almost undetectable already for the 10-PCSL,
while for G38K a reduced, but still a signiﬁcant S increase is observed
up to the more internal spin label, 12-PCSL. However, we were not
able to detect the appearance of a second, more motionally restricted
component in the spectrum (see Fig. 4A), thus indicating that both BS-
RNase and G38K do not penetrate deeply into the membrane interior
[50], but remain conﬁned to a quite external region of the bilayer
although, in the case of G38K, perturbations due to the protein
effectively propagate along the lipid acyl chains.
We also investigated the inﬂuence of the protein/lipid weight ratio
on the order parameter of 5-PCSL in DLPG membranes, observing
for both BS-RNase and G38K a continuous increase of S value (Fig. 5).
This behavior is in contrast with the saturation trend usually ob-
served for transmembrane proteins, or for proteins which steadily
resides in the bilayer structure, thus suggesting a dynamic interaction,
i.e., a fast exchange regime between the proteins and the bilayer.
4. Conclusions
Knowledge of structural details that drive macromolecular recog-
nition and interactions is essential not only to understand biological
processes, but also to improve their efﬁciency and speciﬁcity in view
of possible pharmacological applications. Based on these consider-
ations, we have performed a careful study of the membrane inter-
action mechanism of BS-RNase, which represent a crucial aspect for
its antitumor activity. We have also designed and characterized a
BS-RNase variant with an increased toxic activity toward tumor cells
by substituting a glycine residue on the protein surface with a basic
residue. SPR and ESR studies on BS-RNase and its G38K variant point
to a strong interaction of both enzymes, which are extremely basic
proteins, with anionic phospholipid bilayers, mediated by a similar
interaction mechanism. For both proteins, SPR data suggest a two-
step process, composed by an initial binding to the bilayer surface,
driven by electrostatic interactions, followed by an at least partial
penetration in the lipid core. In turn, ESR data indicate that the
3014 G. D'Errico et al. / Biochimica et Biophysica Acta 1808 (2011) 3007–3015deepness of penetration is quite limited, both proteins remaining
conﬁned in the more external region of the bilayer microstructure.
Despite the shallow insertion, the proteins effectively perturb the
lipid packing and dynamics. In conclusion, our results, while ruling
out the hypothesis that the protein crosses the membrane interior,
support the hypothesis of a BS-RNase entry mediated by an endo-
cytosis mechanism [51].
The comparison of SPR and EPR data show that with respect to
BS-RNase G38K not only binds more strongly to the bilayer surface,
but that the effects of protein-bilayer interaction more effectively
propagate along the lipid acyl chains, perturbing the whole bilayer
proﬁle. Thus it can be concluded that the introduction of a lysine at
position 38, by enhancing the protein-bilayer interaction, favors the
BS-RNase translocation through membranes without altering the
natural mechanism of the process.
This effect could well explain the increased cytotoxic activity of
G38K with respect to the parent BS-RNase, although other concurring
synergistic effects, notably a better resistance to RI of the monomeric
derivative, which is supposed to be produced from the unswapped
isoforms in the reducing cytosolic environment, cannot be completely
excluded. However the substitution of glycine 38 with a basic residue
is expected to play only a minor destabilizing effect, if any, on the
putative complex of the monomeric BS-RNase with RI [44]. Further-
more, we would like to recall here that the swapped isoform of BS-
RNase is already able to evade RI binding, even in the reducing
cytosolic environment [16], whereas the monomeric derivative of
BS-RNase, which represents the product of the less-abundant,
unswapped isomer of BS-RNase in the same reducing conditions is
inhibited from RI. These considerations lead us to conclude that the
increased cytotoxic activity of G38K rely mainly on its better mem-
brane interaction due to the presence of a positive charge cluster on
the protein N-face, providing also a direct hint to design ribonucleases
with even higher, selective, cytotoxic activity.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamem.2011.08.009.Acknowledgements
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